Cannabis Industry Bitcoin's price this year has soared over 290% and last Friday, the price of this cryptocurrency sat at one point $2,544.

The Relationship Between the Cannabis Industry and the Bitcoin Sector

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )



MOUNTAIN HIGH ACQUISITIONS CORP (MYHI) announces that together with D9 Manufacturing, Inc. it is launching a pilot project aimed

MOUNTAIN HIGH ACQUISITIONS CORP (MYHI) rolls out Pilot Program aimed at helping Licensed Cannabis Growers

Mountain High Acquisitions Corp. rolls out Pilot Program aimed at helping Licensed Cannabis Growers overcome a Key Challenge–Financing Startup Infrastructure Costs

MOUNTAIN HIGH ACQUISITIONS CORP <span data-recalc-dims=(MYHI) announces that together with D9 Manufacturing, Inc. it is launching a pilot project aimed " width="300" height="130" srcset="https://i0.wp.com/investorsbuz.com/wp-content/uploads/2017/07/logo.png?resize=300%2C130&ssl=1 300w, https://i0.wp.com/investorsbuz.com/wp-content/uploads/2017/07/logo.png?resize=768%2C333&ssl=1 768w, https://i0.wp.com/investorsbuz.com/wp-content/uploads/2017/07/logo.png?w=800&ssl=1 800w" sizes="(max-width: 300px) 100vw, 300px" />

FOREX INVESTORS  PRESS RELEASE  MOUNTAIN HIGH ACQUISITIONS CORP (MYHI) announces that together with D9 Manufacturing, Inc. it is launching a pilot project aimed at proving a turnkey infrastructure model MYHI intends to roll out in highly promising cannabis markets such as California, Washington and Arizona.  The objective is to help licensed cannabis growers overcome the key business challenge of financing steep startup infrastructure costs.
To initiate the project, MYHI has acquired two state-of-the-art intermodal containers engineered and designed specifically for growing cannabis.  The opportunity to acquire the grow containers was presented to MYHI by D9 Manufacturing, Inc., an Arizona based company that offers a wide variety of engineering, manufacturing and consulting services to the cannabis sector.  On May 30, MYHI announced the engagement of D9 to assist in the identification, acquisition and development of infrastructure opportunities in the cannabis market.

“We are very enthusiastic about pursuing this opportunity, and appreciate what D9 has brought to the table so quickly. The solutions we intend to provide to the cannabis industry solve real problems faced by licensed growers and producers.  Having a license is not a guarantee of success.  A grower needs infrastructure and equipment that maximizes the quantity and quality of their production—and all of that can be expensive,” said MYHI CEO Alan Smith.

“That’s where we come in.  By providing swift access to affordable turnkey solutions not only do we greatly reduce setup time and costs and help growers get growing, we also help them to minimize risk and optimize their business.”




MOUNTAIN HIGH ACQUISITIONS

 

As a part of this initial pilot, MYHI will lease its first two containers to D9 for use in licensed grow operations in Arizona and California.  Grow operations in the containers are expected to begin within 30 days.  Initial harvests are anticipated to occur 90 days later.

This particular pilot project will allow the company to test both the revenue model—acquiring and leasing infrastructure solutions to licensed growers—and the equipment itself.  In this case the equipment being leased out consists of intermodal containers that can be geared for cultivation or for extraction depending upon how the container is built out.

“This pilot is just the beginning,” said Ferrel Raskin, CEO of D9 Manufacturing, Inc. “We have identified further opportunities for MYHI and D9 to pursue once this revenue model has been vetted and fine-tuned. The reality is that the cannabis industry has now matured enough so that we can identify common problems and challenges and, in turn, provide easier access to meaningful solutions.  We’re excited to be working with a partner like MYHI to ensure that these solutions are backed by sound business expertise and the ability to raise the capital required.”

About Mountain High

Mountain High Acquisitions Corp. (MYHI) is a holding company focused on the acquisition and development of businesses and other assets within the cannabis sector. For additional information please contact Alan Smith at info@mountainhighac.com.Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




New Colombia Resources, Inc. (“the Company”) ( OTC : NEWC ), a Colombian natural resource company listed in the U.S., with premium metallurgical

New Colombia Resources, Inc. (NEWC) has been Granted Colombia’s First Health Registry Approval for Cannabis based Products

New Colombia Resources Announces Sannabis has been Granted Colombia’s First Health Registry Approval for Cannabis based Products

New Colombia Resources, Inc. (“the Company”) ( OTC : NEWC ), a Colombian natural resource company listed in the U.S., with premium metallurgical

BUZ INVESTORS  PRESS RELEASE  New Colombia Resources, Inc. (“the Company”) ( OTC : NEWC ), a Colombian natural resource company listed in the U.S., with premium metallurgical coal and medical marijuana assets, announces their joint venture in Colombia, Sannabis, has received a “Registro Sanitario” from Colombia’s Ministry of Health’s INVIMA (National Institute for Food and Drug Monitoring).
The Registro Sanitario number is NSOC78859-17CO, this can also be accessed directly on INVIMA’s website by inputing Expediente number 20127339, http://farmacovigilancia.invima.gov.co:8082/Consultas/consultas/consreg_encabcum.jsp

Their registry number is for 10 brands, but only four were registered; Sannaxhol (pain relief, anti-inflammatory), Sannaderm (for skin abrasion and post tattoo care), Sannalip (lip balm), and a product soon to be announced. The Company plans to register an additional six products possibly through joint ventures for worldwide distribution. These products are manufactured by an INVIMA certified manufacturing facility with Good Manufacturing Practices (GMP). Potential joint venture partners or licensees are welcome to contact New Colombia Resources at jcampo@newcolombiaresources.com.




New Colombia Resources,

 

New Colombia Resources will begin marketing Sannaxhol in the U.S. with retired Colombian Major League Baseball World Series MVP, Edgar Renteria, also a shareholder of New Colombia Resources, Inc. Mr. Renteria’s was chosen by MLB to manage the World Team during this year’s All Star Week in Miami. This platform will be used by New Colombia Resources to launch Sannaxhol, an effective anti-inflammatory pain product, in the U.S.

Sannabis has first mover advantage while others try to position themselves as Colombia’s new medical marijuana regulations are implemented. New Colombia Resource’s joint venture in Colombia, Sannabis SAS, has been legally producing non-smoked medical marijuana products since 2014, their in-house doctor and others prescribe these products to patients. Sannabis supports small producers legally on an Indian reservation creating opportunity for local farmers to grow medical marijuana legally verses initiating illegal crops. Sannabis supports indigenous farmers that are small producers taking pride in their medicines that provide relief and potentially save lives.

Sannabis is carefully monitoring the issuance of the resolution to regulate medical marijuana to apply for the appropriate licenses that will continue to help small producers. To see the Sannabis catalog with technical specifications of their products visit, http://www.sannabis.co/ver-catalogo

New Colombia Resources is working with a partner to submit an application for an orphan drug designation for a pharmaceutical product that will be announced upon submission. In the meantime, the Company will file the health registries of the four products approved by INVIMA with the U.S. Food and Drug Administration (FDA), INVIMA’s registry is recognized by the U.S. FDA and most health departments around the world. These products are derived from hemp seed oil which can legally be imported into the United States with a THC level under .3%.

“Most hemp seed products are imported to the United States from Canada. Needless to say, Colombia has more ideal growing conditions than Canada, evidenced by the Canadian medical marijuana companies down here trying to set up shop. We’re positioning ourselves as a leading distributor of high quality ‘Made in Colombia’ medical marijuana and hemp products around the world,” stated John Campo, President of New Colombia Resources, Inc.

New Colombia Resources would also like to announce their auditors have informed them to expect their first SEC filings to be ready this week, if all goes well. The Company is very committed to being SEC compliant.

New Colombia’s President, John Campo, was recently interviewed by S&P Global Market Intelligence, for a copy of that report visit, http://www.snl.com/web/client?auth=inherit – news/article?id=40765771&cdid=A-40765771-10290

Sannabis products made headlines recently in Colombia when their Cannabis Exhibition in the halls of Congress was abruptly cancelled by the President of the Senate for political reasons, to view the news clip visit, https://www.facebook.com/sannabis.oficial/videos/vb.1064330270249615/1763729956976306/?type=2&theater

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




American Cannabis Company, Inc. Announces It Has Secured Their Second Client In The State Of Maryland

American Cannabis Company, Inc. (AMMJ) Secured A Contract With A New Client In Colorado

American Cannabis Company, Inc. Announces It Has Secured A Contract With A New Client In Colorado

American Cannabis Company, Inc. Announces It Has Secured Their Second Client In The State Of Maryland

BUZ INVESTORS  PRESS RELEASE  American Cannabis Company  American Cannabis Company, Inc. ( OTCQB : AMMJ ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced it has secured a local client in the state of Colorado. This client, Bud Fox Enterprises LLC and Ty Webb Enterprises LLC, will have a multi-location business comprised of state-of-the-art greenhouse cultivation and extraction. ACC will provide end-to-end solutions for this new client, which include operational planning activities, conceptual design work, application completion, deployment of operations and ongoing remote management. ACC has worked with its set of preferred vendors and technology to provide this client with a top-notch business infrastructure.
Mark Prescott, CEO of Bud Fox Enterprises LLC and Ty Webb Enterprises LLC, commented: “My company is in the process of becoming a next generation cannabis business within the sector, and I thank the ACC team for creating the foundation that will lead to both our success and future growth. ACC is providing us with state-of-the-art cultivation equipment and methodologies that are sure to give way to a consistent, top-tier product. Our cultivation environment will feature a fully outfitted greenhouse that utilizes the full spectrum of the sun, low water usage and ACC’s proprietary SoHum Living Soils®. The SoHum Living Soils® product will cut our costs down tremendously in the cultivation phases, as this fully amended blend provides a plant with the appropriate amount of nutrients for its entire life cycle. This eliminates the need to purchase any nutrients or additives which will ultimately lower our total cost of production per harvest. This consulting firm is unlike any other, and once we engaged with ACC it was very easy to see what sets them apart from the rest of their competition.”




American Cannabis Company

Terry Buffalo, CEO of American Cannabis Company, commented: “We are happy to have secured this relationship with a Colorado-based client. Our team is committed to promoting the success of our client, and we are confident that they will flourish in the local cannabis marketplace. This client’s build out is rather unique, and operators as well as all visitors who walk through these facilities will be able to truly grasp the future of cannabis.”

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. American Cannabis Company also developed and owns a portfolio of branded products including: The Satchel™, Sohum Living Soils™, The Cultivation Cube™ and The High Density Cultivation System™. We also design and provide other industry specific custom product solutions. The building and development of our brands and product suite is based on our Geoponics Philosophy, “the art and science of agriculture in soil.”

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




Global Cannabis Appoints  Global Cannabis Applications Corp. ("GCAC" or the "Company") (cse:APP) (2FA) (otcqb:FUAPF), a leading developer of innovative smartphone applications for the cannabis industry,

Global Cannabis Appoints Managing Director for Australia

Global Cannabis Appoints Managing Director for Australia

 

Global Cannabis Appoints  Global Cannabis Applications Corp. ("GCAC" or the "Company") <span data-recalc-dims=(cse:APP) (2FA) (otcqb:FUAPF), a leading developer of innovative smartphone applications for the cannabis industry," width="300" height="213" srcset="https://i0.wp.com/investorsbuz.com/wp-content/uploads/2017/06/gcm-Small.jpg?resize=300%2C213&ssl=1 300w, https://i0.wp.com/investorsbuz.com/wp-content/uploads/2017/06/gcm-Small.jpg?resize=322%2C230&ssl=1 322w, https://i0.wp.com/investorsbuz.com/wp-content/uploads/2017/06/gcm-Small.jpg?w=676&ssl=1 676w" sizes="(max-width: 300px) 100vw, 300px" />

BUZ INVESTORS  PRESS RELEASE  Global Cannabis Appoints  Global Cannabis Applications Corp. (“GCAC” or the “Company”) (cse:APP) (2FA) (otcqb:FUAPF), a leading developer of innovative smartphone applications for the cannabis industry, is pleased to announce it has established a presence in Australia with the appointment of Jason Webb as Managing Director for Australian Operations.

Jason Webb has extensive experience in tech commercialisation in Australia and has helped build a number of businesses in cutting edge sectors such as FinTech (financial technology) and RegTech (regulation technology).

Brad Moore, CEO of GCAC, states, “Mr. Webb will help GCAC become a cornerstone for medical research, medical apps development and IP licencing. He will be tasked with securing contracts with leading health, government, tech, providers and medical cannabis accelerators.”

In November 2016, the Australian Therapeutic Goods Administration (TGA) moved medical cannabis from a Schedule 9 product to a Schedule 8, immediately creating a legal market for the sale and commercialisation of medical cannabis in Australia. Australia is now seen as an important market for medical cannabis along with other countries including Canada, the Netherlands, Israel, France, and the United States.




Global Cannabis Appoints

“I am very excited to be involved with GCAC and the medical cannabis industry in Australia,” says Webb. “The unique IP contained in GCAC’s propriety ‘Pain To Strain’ database developed over 20 years will be pivotal in helping the medical cannabis industry grow in Australia.”

Mr. Webb will also be engaging industry input for GCAC’s CannaMed app that will be launched to help the estimated 750,000 existing medical cannabis patients in Australia and to connect patients to pharmacies to GP’s for better health outcomes.

“Medical cannabis is a very exciting opportunity. However, the most exciting opportunity will be the significant insights from the big data that flows out from this new frontier,”‘ says Jason Webb. “Though regulation in Australia has provided permission to patients to use medical cannabis, it has not yet allowed specialists to promote to patients how to access medical cannabis. The CannaMed app will fill this gap,” says Webb.

The CannaMed app is built upon the Citizen Green tech stack and incorporates the proprietary “Pain To Strain” database, matching ailments to beneficial cannabinoids. Though the CannaMed app will be available to the Australian public on IOS and Android by January 2018, the Pain To Strain database is available for scientific research consideration immediately.

GCAC Australia will be based in Melbourne, Australia, and operational effective August 2017.

About Global Cannabis Applications Corp.

Global Cannabis Applications Corp. is a global leader in designing, developing, marketing, and acquiring innovative mobile applications. Used in over 25 countries, GCAC’s apps facilitate the proliferation of digital conversations by like-minded people. Managed by digital industry experts, GCAC is focused on viral global expansion by providing the best user experience in each target market. Its leading mobile platforms are Citizen Green, a family of apps dedicated to the digital world of all things cannabis; Foro, a peer-to-peer mobile ecommerce student marketplace; Opinit, an app that enables users to socially share their favourite online sentiment-driven content; and Truth, a one-to-one anonymous messaging app.

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE:APP, FSE:2FA, OTCQB:FUAPF), a leading developer of innovative smartphone applications for the cannabis industry, announces it will

Global Cannabis To Launch Cannamed And Cannalife Apps

Global Cannabis To Launch Cannamed And Cannalife Apps

 

Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE:APP, FSE:2FA, OTCQB:FUAPF), a leading developer of innovative smartphone applications for the cannabis industry, announces it will

BUZ INVESTORS PRESS RELEASE  Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE:APP, FSE:2FA, OTCQB:FUAPF), a leading developer of innovative smartphone applications for the cannabis industry, announces it will launch two medical cannabis applications for the global medical cannabis market.

In early July 2017, GCAC will launch Citizen Green’s CannaMed and CannaLife, two apps built specifically for new and existing global medical cannabis users that will be available in German, English, Italian, French and Spanish across the globe.  Both applications utilize GCAC’s CannaCube Pain To Strain™ user-friendly technology that incorporates a proprietary database of over 10 years of field research that uniquely allows medicinal cannabis users to create individual user profile preferences to address one or multiple conditions for which they seek therapeutic benefits

Built from the original Citizen Green app code base, CannaMed users worldwide can learn more about the medical cannabis products they are using and read other users’ feedback as well as provide their own.




Global Cannabis

The highly customizable user profile assists CannaMed users in discovering other options that have helped patients with the same condition.  By turning on or off certain product attributes, CannaMed users can view a wide array of product options and reviews to personalize their experience even more.  Where cannabis is legally sold in dispensaries, online or pharmacies, CannaMed displays the best product options on an interactive map.

GCAC’s CannaLife is the first medicinal cannabis-related social media platform of its kind.  Similar to CannaMed, users create a unique user profile using CannaCube, allowing them to create unique profile preferences.  Using the information from these preferences, CannaLife users have access to multiple options based on topics of interest.  Using a dedicated cannabis-specific in-app search engine, CannaLife users can create and post content, join or create related topic-based communities, tag topics across multiple platforms, share information and receive and send alerts.  Both CannaLife and CannaMed are both joined by a single sign on process, similar to leading apps like Facebook and Instagram, allowing user community bases to easily share and grow.

The Company’s business is focused on big data, aggregated through mobile technology that enables patients, doctors, pharmacists, providers and practitioners to more easily identify key strains of cannabis that have the most benefit to target ailments and foster personal well being.  Unique to GCAC is the integration of user-generated data aggregated over 10 years of observational reports for pain relief / benefits, matched to a derived strain of cannabis or plant extract.

States CEO Brad Moore, “Unlike other online marijuana resources  that have been purely recreational, all Citizen Green apps are truly about medical cannabis.  We are using an innovative approach of technology and user rich data to help our app users learn, understand and participate in the growing world of medical cannabis.”

About Global Cannabis Applications Corp.

Global Cannabis Applications Corp. is a global leader in designing, developing, marketing, and acquiring innovative mobile applications.  Used in over 25 countries, GCAC’s apps facilitate the proliferation of digital conversations by like-minded people.  Managed by digital industry experts, GCAC is focused on viral global expansion by providing the best user experience in each target market.  Its leading mobile platforms are Citizen Green, a family of apps dedicated to the digital world of all things cannabis; Foro, a peer-to-peer mobile ecommerce student marketplace; Opinit, an app that enables users to socially share their favourite online sentiment-driven content; and Truth, a one-to-one anonymous messaging app.

For more information about the Company, please visit online at www.cannappscorp.com, or review its profiles on the SEDAR website (www.sedar.com) and on the Canadian Securities Exchange’s website (www.thecse.com).




American Cannabis Company, Inc. Announces It Has Secured Their Second Client In The State Of Maryland

American Cannabis Company, Inc. AMMJ Announces It Has Secured A Contract With A New Client In Ohio

American Cannabis Company, Inc. Announces It Has Secured A Contract With A New Client In Ohio

BUZ INVESTORS  PRESS RELEAASE  AMMJ Announces It Has Secured A Contract American Cannabis Company, Inc. ( OTCQB : AMMJ ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced it has secured its second client in the state of Ohio. ACC will be working with this client to strategically plan business operations in effort to win a license to legally operate a vertically integrated cannabis business within the state.
ACC will provide end-to-end solutions for this new client, which include operational planning activities, conceptual design work, application completion, deployment of operations and ongoing remote management. ACC expects to leverage this contract to secure additional revenues through long-term consulting agreements and potential future sales of ancillary products.

 

Terry Buffalo, CEO of American Cannabis Company, commented: “We are happy to announce that we have secured our second client in the state of Ohio. No matter where the market is, it takes a knowledgeable project management team and motivated client to produce, organize and finalize these license application materials. This up-and-coming state cannabis program is already stacking up to be a competitive market, but we feel that our client is prepared to do what it takes to not only secure licensure but also thrive in the space.”

AMMJ Announces It Has Secured A Contract

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. American Cannabis Company also developed and owns a portfolio of branded products including: The Satchel™, SoHum Living Soils™, The Cultivation Cube™ and The High Density Cultivation System™. We also design and provide other industry specific custom product solutions. The building and development of our brands and product suite is based on our Geoponics Philosophy, “the art and science of agriculture in soil.”

For more information, please visit:
www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.sohumsoils.com

Business Description

Industry: Farm & Construction Machinery » Farm & Construction Equipment    NAICS: 333111    SIC: 3523
Compare: OTCPK:(SRNA), NAS:(ARTW), OTCPK:(INQD), OTCPK:(FBRKF), NAS:(ASV), OTCPK:(TRTC),

NAS:(GENC), OTCPK:(SNYYF), NAS:(CMCO), OTCPK:(AGGZF), NYSE:(TWI), NYSE:(MTW),

NYSE:(LNN), NYSE:(ALG), NAS:(ASTE), OTCPK:(WKRCF), NYSE:(JOY), NYSE:(TEX),

OTCPK:(ZLIOY), OTCPK:(HTCMY) » details

Headquarter Location: USA

American Cannabis Co Inc provides end-to-end consulting and product solutions for the medical, adult use and low-THC regulated cannabis markets both nationally and internationally.

 

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )

VPR Brands, LP will be attending as well as speaking at the 2017 MoneyShow in Orlando

VPR Brands, LP VPRB will be sponsoring the Cannabis World Congress and Business Exposition

|Chart | Calendar   | TRADE NOW | VPRB

VPR Brands, LP will be sponsoring the Cannabis World Congress and Business Exposition

 

BUZ INVESTORS  PRESS RELEASE   VPRB will be sponsoring the Cannabis World Congress VPR Brands, LP ( OTC PINK : VPRB ), a market leader specializing in vaporizers and accessories for essential oils, cannabis concentrates, and extracts, will be a sponsor of the The Cannabis World Congress & Business Expo (CWCBExpo) at the Jacob K. Javits Center in New York this June 14-16th. The CWCBExpo is the definitive business event for the cannabis industry. Exhibitors and sponsors bring cutting-edge solutions to owners and managers of businesses in this fast-growing industry, and a wealth of opportunity and knowledge to those looking to enter the market with potential partners and investors.
“We have decided that sponsoring the event, which will give us the opportunity to insert one of our catalogs into every attendee bag when they arrive, would be best the best way to showcase our products, which are the cornerstone of our company. The evolution of our HONEYSTICK brand offering has grown exponentially in 2017 and our new catalog and website have been very well received by our customers. We have printed and have and will be distributing over 25,000 of our new product catalogs at trade events such as this as well as through our distributor partners just in the second quarter alone. Sponsorships like this will continue to be part of our and sales and marketing plan going forward,” said Kevin Frija, CEO of VPR Brands, LP.

“This is the largest Cannabis Conference in the Northeastern United States, with a very diverse exhibitor roster and some very famous presenters and other industry experts speaking. It is a great event for us to sponsor to show our support for the industry and further expand and create awareness of our HONSYSTICK Brand.”




VPRB will be sponsoring the Cannabis World Congress

 

About Cannabis World Congress & Business Expositions (CWCBExpo)
The professionally run Cannabis World Congress & Business Expositions (CWCBExpo) are produced by Leading Edge Expositions in partnership with the International Cannabis Association (ICA). The events are the premier professional forums for dispensary owners, growers, suppliers, investors, medical professionals, government regulators, legal counsel, and entrepreneurs looking to achieve business success and identify new areas of growth in this dynamic industry. To learn more about the coast-to-coast CWCBExpos in New York, Los Angeles and Boston, go to www.cwcbexpo.com.

About VPR Brands, LP:
VPR Brands is a technology company, whose assets include issued U.S. and Chinese patents for atomization related products including technology for medical marijuana vaporizers and electronic cigarette products and components. The company is also engaged in product development for the vapor or vaping market, including e-liquids. Vaporizers and electronic cigarettes (also known as e-cigarettes) are devices which deliver nicotine and or cannabis through atomization or vaping, and without smoke and other chemical constituents typically found in traditional products. For more information about VPR Brands, please visit the company on the web at www.vprbrands.com and www.vapehoneystick.com

 

bb) Mstart(0)--sm Mstart(0)--md Mstart(33.3%) P(20px) W(1/1)--sm W(1/1)--md ie-7_W(45%)" data-reactid="38">
r) M(a) Maw(600px) Maw(800px)--lg Mih(650px) Mih(0)--sm" data-reactid="39">

 VPRB will be sponsoring the Cannabis World Congress

bb) Mstart(0)--sm Mstart(0)--md Mstart(33.3%) P(20px) W(1/1)--sm W(1/1)--md ie-7_W(45%)" data-reactid="38">
r) M(a) Maw(600px) Maw(800px)--lg Mih(650px) Mih(0)--sm" data-reactid="39">
r)" data-reactid="2">
bw) Cl(start) Mb(20px) Fz(15px) Lh(1.6) C(#26282a) Ff($ff-secondary) D(i)" data-reactid="10">

Business Description

Industry: Tobacco Products » Tobacco    NAICS: 312230    SIC: 2111
Compare: OTCPK:(GLLA), OTCPK:(SRUP), OTCPK:(VAPI), OTCPK:(RCGR), OTCPK:(NHLE), OTCPK:(BXNG), OTCPK:(MCIG), NYSE:(AOI), NYSE:(TPB), NYSE:(UVV), NYSE:(VGR), OTCPK:(SWMAY), OTCPK:(GGNPF), OTCPK:(IMBBF), OTCPK(:JAPAY), NYSE:(RAI) OTCPK:(BTAFF), NYSE:(MO), NYSE:(PM) » details
Headquarter Location: USA

VPR Brands LP is a technology company. It is engaged in product development for the vapor or vaping market, including e-liquids, vaporizers and electronic cigarettes devices, that delivers nicotine and or cannabis through atomization or vaping.

VPR Brands LP, formerly Soleil Capital LP was incorporated in New York on July 19, 2004, as Jobsinsite.com, Inc. It is engaged in the electronic cigarette and personal vaporizer industry. The Company competes against ” big tobacco”, U.S. cigarette manufacturers of both conventional tobacco cigarettes and electronic cigarettes like Altria Group, Inc., Lorillard, Inc. and Reynolds American, Inc. It competes against ” big tobacco” who offers not only conventional tobacco cigarettes and electronic cigarettes but also smokeless tobacco products such as “snus” (a form of moist ground smokeless tobacco that is usually sold in sachet form that resembles small tea bags), chewing tobacco and snuff. It owns a portfolio of electronic cigarette and personal vaporizer patents.

 

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )




BUZ INVESTORS Definitive Agreement Tetra Bio-Pharma Inc. (“Tetra” orCN)announced today

Tetra Bio-Pharma Inc. (TBP) (TBPMF) Announces UNB Cannabis Health Research Chair

|Chart | Calendar   | TRADE NOW | CANNABIS

Tetra Bio-Pharma Announces UNB Cannabis Health Research Chair

 

BUZ INVESTORS  PRESS RELEASE  UNB Cannabis Health Research Chair Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (CSE:TBP)(TBP.CN)(CNSX:TBP)(TBPMF) and The New Brunswick Health Research Foundation are investing a combined $1 million, $500,000 each over five years to establish a Health Research Chair in Cannabis at the University of New Brunswick (UNB).
The chair will focus on the study of biochemistry, medicinal use and pharmacology of cannabis. This research will expand UNB’s commitment to research and innovation in the field of natural product and biomedical, health and life sciences – adding to its reputation as a leader in natural products’ research.

“The Cannabis Health Research Chair is a key example of the university’s commitment to discovery,” says Dr. David Burns, Vice-President (Research), UNB. “We believe in the power of research to advance innovation within New Brunswick. With 75 per cent of the province’s public funded research taking place at UNB, we’re thrilled to play a central role.”

Potential research areas for the chair include the analysis of existing cannabis literature, in order to understand inconsistencies and identify needs for future research; the biochemistry and medicinal chemistry analyses of cannabis; and preclinical pharmacology studies.

“Health research is instrumental in helping us find better ways to provide patient care in our province,” says Health Minister Victor Boudreau. “This new Cannabis Research Chair will certainly provide crucial and innovative information on the use of cannabis as a medical treatment.”




 

UNB Cannabis Health Research Chair

“We are honoured to invest with the New Brunswick Health Foundation in establishing a research chair at the University of New Brunswick as Tetra positions itself as a global leader in pharmaceutical cannabis,” said Andre Rancourt, CEO of Tetra Bio-Pharma.

The recruitment and nomination process will be conducted at the University of New Brunswick for a tenured track faculty member. Funding for the chair is expected to start in the 2017-18 fiscal year.

Dr. Guy Chamberland, Chief Scientific Officer of Tetra Bio-Pharma added: “Over the past few years, the province of New Brunswick has positioned itself on the forefront as global leaders in the development of cannabis products for health care. The Tetra team has partnered with the New Brunswick Health Research Foundation to help bring innovative cannabis-based therapies to patients. We have no doubt that when established, the work of this new chair will contribute significantly to this network by providing crucial information on the safety toward implementing new cannabis based products to practitioners working to help improve the quality of life for patients specifically living with chronic pain.”

This research will expand the university’s capacity to train, mentor and prepare undergraduate and graduate students to work effectively in botanical product research.

“The present Health Research Chair, the second one announced within a month, clearly signifies New Brunswick’s intention to be at the forefront of cannabis research. This competitive Chair will further develop the science toward implementing proven and safe innovative cannabis-based therapies for the chronic treatment of various disorders (pain, PTSD, etc.),” says Dr. Bruno Battistini, President, CEO and Scientific Director of the New Brunswick Health Research Foundation.

“New Brunswick, with such entities as UNB, the NB Research and Productivity Council, and Tetra Bio-Pharma as the private sector partner, create a unique association, leveraging scientific and innovation expertise that will strongly address the clinical challenges introduced by the legalization and regulation of this natural product.”

About Tetra Bio-Pharma:

Tetra Bio-Pharma is a multi subsidiary publicly traded company (CSE:TBP) (TBPMF) engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio-Pharma is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. More information is available about the company at: www.tetrabiopharma.com.

Business Description

Industry: Biotechnology » Biotechnology    NAICS: 325411    SIC: 3741
Compare: NAS:(CXRX), OTCPK:(FENCF),

Business Description

Industry: Biotechnology » Biotechnology    NAICS: 325411    SIC: 3741
Compare: NAS:CXRXOTCPK:FENCFNAS:MTPNAS:EGLTNAS:ECYTNAS:IPCINAS:SNSSNAS:APENNAS:NVIVNAS:NOVNNAS:FLKSNAS:AKTXNAS:CURNAS:SRRANAS:LPTXOTCPK:ORGSNAS:CTICNAS:CASINAS:XENENAS:KMPH » details
Traded in other countries: TBP.CanadaJAM1.Germany,
Headquarter Location: Canada

NAS:(MTP), NAS:(EGLT), NAS:(ECYT), NAS:(IPCI), NAS:(SNSS),

NAS:(APEN), NAS:(NVIV), NAS:(NOVN), NAS:(FLKS), NAS:(AKTX), NAS:(CUR), NAS:(SRRA),

NAS:(LPTX), OTCPK:(ORGS), NAS:(CTIC), NAS:(CASI), NAS:(XENE), NAS:(KMPH) » details

Traded in other countries: TBP.CanadaJAM1.Germany,
Headquarter Location: Canada

Tetra Bio Pharma Inc is a multi-subsidiary publicly traded company. It is engaged in the development of Bio Pharmaceuticals and Natural Health Products containing Cannabis and other medicinal plant based elements.

Tetra Bio Pharma Inc is a multi-subsidiary publicly traded company engaged in the development of Bio Pharmaceuticals and Natural Health Products. The company is engaged in pain management research including medical marijuana, consultations and acquisitions, with an ongoing license application to become a producer of medical marijuana in Canada. It combines traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies.

 

Like up on FACEBOOK


logo



Pharmaceuticals  stocks ( CGC)  ( JNJ ) ( MRK ) ( GSK ) ( celg )  ( gild )